The Pressure-controlled Intermittent Coronary Sinus Occlusion on VentrIcular PERformance Study

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

December 29, 2022

Study Completion Date

December 29, 2022

Conditions
Myocardial Infarction
Interventions
DEVICE

PICSO

"PICSO therapy is delivered through the PICSO Impulse System, which consists of the PICSO Impulse console and PICSO impulse catheter. The PICSO therapy is delivered in each patient for a minimum of 20 minutes to a maximum of 45 minutes.~The PICSO Impulse catheter is automatically activated by the PICSO Impulse console. It is inserted in the coronary sinus via femoral vein access. The PICSO Impulse Console cyclically inflates and deflates the balloon at the tip of the PICSO Impulse catheter, generating transient increase in coronary sinus pressure."

Trial Locations (1)

OX39DU

Oxford Heart Centre, Oxford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Miracor Medical SA

INDUSTRY

lead

Oxford University Hospitals NHS Trust

OTHER

NCT04032925 - The Pressure-controlled Intermittent Coronary Sinus Occlusion on VentrIcular PERformance Study | Biotech Hunter | Biotech Hunter